Central America imports more than 85% of its medicines from outside the region despite the progress of its pharmaceutical industry, reports Inquifar report
The acquisitions of this segment amounted to USD 4,321.1 million in 2025, while intraregional trade accounted for only 14% of the supply and..
- Center3
2 agency rewrites / co-publications detected
Summary
The acquisitions of this segment amounted to USD 4,321.1 million in 2025, while intraregional trade accounted for only 14% of the supply and Guatemala led external sales with USD 422.7 million. Central America imports more than 85% of its medicines from outside the region despite the progress of its pharmaceutical industry, reports from Inquifar.
Cross-referenced from 3 sources.
Factual coreconfirmed by several independent voices
The acquisitions of this segment amounted to USD 4,321.1 million in 2025, while intraregional trade accounted for only 14% of the supply and Guatemala led external sales with USD 422.7 million
reliability low1/3 sourcesCentral America imports more than 85% of its medicines from outside the region despite the progress of its pharmaceutical industry, reports from Inquifar.
reliability low1/3 sources
Disputedincompatible versions — to verify
No factual contradiction detected between sources.
Framing by sidesame fact, different words — loaded terms highlighted
No notable framing divergence.
Blind spotwhat one side keeps silent
No blind spot detected: every side covers the same facts.
Sources1 source cross-checked
Center1